not tagged
CRISPR therapeutics AG
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
meet us today at #eha2022 during the poster session and learn about adapting crispr/cas9 to aml pdx by diana amend, presented by p423 streamlining preclinical trials by p323 insights regarding kras and npm1 by yuqiao gao p402
We study primary #AcuteLeukemia in patient-derived xenograft in vivo using genetic engineering to identify new treatments. #TranslationalCancerResearch